Community-based accompaniment with supervised antiretrovirals in Lima, Peru
在秘鲁利马以社区为基础配合监督抗逆转录病毒药物
基本信息
- 批准号:8257978
- 负责人:
- 金额:$ 62.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-17 至 2014-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAdherenceAdoptionAffectAnti-Retroviral AgentsBehaviorClinicalClinical TrialsCommunitiesComplexControl GroupsCost Effectiveness AnalysisCountryDataDeveloping CountriesDevelopmentDirectly Observed TherapyDoseEligibility DeterminationEnrollmentEvaluationFailureHIVHealthHeterogeneityHighly Active Antiretroviral TherapyIncomeIndividualInterventionLifeLinkMediatingMethodsModelingOutcomeOutcome StudyParticipantPatientsPeruPlayPopulation StudyPovertyPublishingRandomized Controlled TrialsResearchResearch PriorityResourcesReview LiteratureRiskSalvage TherapySocial NetworkSocial supportStigmataSubgroupSubstance abuse problemSupervisionTarget PopulationsTestingTreatment EffectivenessTreatment EfficacyUnited StatesViral Load resultVisitVulnerable PopulationsWorkantiretroviral therapybasecost effectivecost effectivenessdesignexperienceimprovedinnovationintervention effectmemberpsychosocialpublic health relevancerandomized trialscale upsocial capitalsocial stigmastandard carestandard of carestress managementtherapy designtreatment adherencetreatment strategy
项目摘要
DESCRIPTION (provided by applicant): We propose a cluster-randomized trial to assess the impact of community-based DOT-HAART on HIV-positive individuals and community members in Lima, Peru. We will enroll individuals living in extreme poverty who are starting either first-line HAART or salvage therapy due to virologic failure. Those residing in intervention clusters will receive 12 months of DOT-HAART. We aim to 1) assess the proportion with suppressed HIV viral load at 18 and 24 months after starting HAART among those receiving community-based DOT-HAART versus the control group; 2) compare social capital among community members in DOT-HAART versus control communities; and 3) assess the cost-effectiveness of community-based DOT-HAART. Innovative aspects of this proposal include 1) a targeted intervention for the most vulnerable subgroup of individuals starting HAART (i.e. those living in extreme poverty); 2) a community- based DOT-HAART intervention designed specifically to achieve long-term efficacy; 3) cost- effectiveness analysis; and 4) assessment of the intervention effect on community-level social capital. These study components will inform how best to design and implement DOT-HAART strategies in Peru and other resource-poor settings. By offering a practical, efficacious and cost-effective model of DOT-HAART for resource-poor settings, the findings of this study could improve global efforts to achieve excellent long-term clinical outcomes among individuals on HAART. PUBLIC HEALTH RELEVANCE: Given the limited resources and magnitude of human immunodeficiency virus (HIV) treatment scale-up in resource-poor countries, cost-effective, efficacious adherence interventions for resource-poor settings are urgently needed. Despite accumulating evidence that directly observed therapy of highly active antiretroviral therapy (DOT- HAART) is effective, how best to apply DOT-HAART in resource-poor settings remains unanswered. Development of DOT-HAART interventions with long-term efficacy, refinement of target populations, and evaluation of cost-effectiveness are all scientific research priorities that are urgently needed to inform efforts to implement DOT-HAART in settings with limited resources.
描述(由申请人提供):我们提议进行一项整群随机试验,以评估基于社区的 DOT-HAART 对秘鲁利马的 HIV 阳性个体和社区成员的影响。我们将招募生活在极端贫困中、因病毒学失败而开始一线 HAART 或挽救治疗的个人。居住在干预集群中的人将接受 12 个月的 DOT-HAART。我们的目标是 1) 评估接受基于社区的 DOT-HAART 的患者与对照组相比,在开始 HAART 后 18 个月和 24 个月时 HIV 病毒载量受到抑制的比例; 2) 比较 DOT-HAART 社区成员与对照社区成员的社会资本; 3) 评估基于社区的 DOT-HAART 的成本效益。该提案的创新之处包括 1) 对开始 HAART 的最弱势群体(即生活在极端贫困中的人)进行有针对性的干预; 2) 专门为实现长期疗效而设计的基于社区的 DOT-HAART 干预措施; 3)成本效益分析; 4)社区层面社会资本干预效果评估。这些研究内容将告知如何在秘鲁和其他资源匮乏的地区最好地设计和实施 DOT-HAART 策略。通过为资源匮乏的环境提供实用、有效且具有成本效益的 DOT-HAART 模型,本研究的结果可以改善全球努力,使 HAART 个体实现优异的长期临床结果。公共卫生相关性:鉴于资源匮乏国家的资源有限和扩大人类免疫缺陷病毒(HIV)治疗规模,迫切需要对资源匮乏地区采取具有成本效益、有效的依从性干预措施。尽管越来越多的证据表明直接观察的高效抗逆转录病毒疗法 (DOT-HAART) 是有效的,但如何在资源匮乏的环境中最好地应用 DOT-HAART 仍然没有答案。开发具有长期疗效的 DOT-HAART 干预措施、细化目标人群以及评估成本效益都是科学研究的重点,迫切需要为在资源有限的环境中实施 DOT-HAART 的努力提供信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SONYA S SHIN其他文献
SONYA S SHIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SONYA S SHIN', 18)}}的其他基金
Reducing Cancer Health Disparities in Navajo Nation
减少纳瓦霍族癌症健康差异
- 批准号:
9146821 - 财政年份:2015
- 资助金额:
$ 62.59万 - 项目类别:
Reducing Cancer Health Disparities in Navajo Nation
减少纳瓦霍族癌症健康差异
- 批准号:
8899964 - 财政年份:2015
- 资助金额:
$ 62.59万 - 项目类别:
Reducing Cancer Health Disparities in Navajo Nation
减少纳瓦霍族癌症健康差异
- 批准号:
9323593 - 财政年份:2015
- 资助金额:
$ 62.59万 - 项目类别:
Community-based accompaniment with supervised antiretrovirals in Lima, Peru
在秘鲁利马以社区为基础配合监督抗逆转录病毒药物
- 批准号:
8071140 - 财政年份:2009
- 资助金额:
$ 62.59万 - 项目类别:
Community-based accompaniment with supervised antiretrovirals in Lima, Peru
在秘鲁利马以社区为基础配合监督抗逆转录病毒药物
- 批准号:
7755260 - 财政年份:2009
- 资助金额:
$ 62.59万 - 项目类别:
Community-based accompaniment with supervised antiretrovirals in Lima, Peru
在秘鲁利马以社区为基础配合监督抗逆转录病毒药物
- 批准号:
8434256 - 财政年份:2009
- 资助金额:
$ 62.59万 - 项目类别:
Community-based accompaniment with supervised antiretrovirals in Lima, Peru
在秘鲁利马以社区为基础配合监督抗逆转录病毒药物
- 批准号:
7895596 - 财政年份:2009
- 资助金额:
$ 62.59万 - 项目类别:
相似国自然基金
基于保护动机理论的新确诊青少年HIV感染者抗病毒治疗依从性“游戏+”健康教育及作用机制研究
- 批准号:82304256
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于前景理论的ADHD用药决策过程与用药依从性内在机制研究
- 批准号:72304279
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于HAPA理论的PCI术后患者运动依从性驱动机制与干预方案构建研究
- 批准号:72304180
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于强化学习AI聊天机器人对MSM开展PrEP服药依从性精准干预模式探索及干预效果研究
- 批准号:82373638
- 批准年份:2023
- 资助金额:59 万元
- 项目类别:面上项目
CAS理论视角下农村老年心血管代谢性共病管理依从性的社区-患者协同机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Mitigating the Impact of Stigma and Shame as a Barrier to Viral Suppression Among MSM Living with HIV and Substance Use Disorders
减轻耻辱感和羞耻感对感染艾滋病毒和药物滥用的 MSM 的病毒抑制造成的影响
- 批准号:
10683694 - 财政年份:2023
- 资助金额:
$ 62.59万 - 项目类别:
Core A: Administrative, Career Development, and Research Integration Core
核心 A:行政、职业发展和研究整合核心
- 批准号:
10630466 - 财政年份:2023
- 资助金额:
$ 62.59万 - 项目类别:
Move and Snooze: Adding insomnia treatment to an exercise program to improve pain outcomes in older adults with knee osteoarthritis
活动和小睡:在锻炼计划中添加失眠治疗,以改善患有膝骨关节炎的老年人的疼痛结果
- 批准号:
10797056 - 财政年份:2023
- 资助金额:
$ 62.59万 - 项目类别:
Implementation Evaluation of PACT Pharmacy Management of Heart Failure in VISN 21
VISN 21 心力衰竭 PACT 药房管理实施评价
- 批准号:
10753388 - 财政年份:2023
- 资助金额:
$ 62.59万 - 项目类别:
Promoting Viral Suppression through the CHAMPS+ Intervention in the Deep South
通过 CHAMPS 干预南部腹地促进病毒抑制
- 批准号:
10819823 - 财政年份:2023
- 资助金额:
$ 62.59万 - 项目类别: